2 Clarke Drive
Cranbury, NJ 08512
© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
July 7th 2021
John P. Leonard, MD, discusses the future of PI3K inhibitors in follicular lymphoma.
July 6th 2021
John P. Leonard, MD, discusses the potential for combination regimens with PI3K inhibitors in follicular lymphoma.
March 20th 2016
John Leonard, MD, medical oncology, at Weill Cornell Medicine and NewYorkPresbyterian Hospital, discusses follicular lymphoma treatment considerations. Treatment options include rituximab and bendamustine, which have been around for sometime, as well as newer agents like obinutuzumab, says Leonard.